Skip to main content

Table 6 Responsiveness (MSSS-88, NRS)

From: Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany

MSSS-88 Subscale

Patients treated with cannabinoid oromucosal spray (n = 24)

Patients not treated with cannabinoid oromucosal spray (n = 42)

 

n

Baseline

Follow-Up

Change baseline to Follow-up

n

Baseline

Follow-Up

Change baseline to Follow-up

  

M ± SD

M ± SD

Mean Difference (SD)

p- value+

Cohen d

 

M ± SD

M ± SD

Mean Difference (SD)

p- value+

Cohen d

Muscle Stiffness

22

76.55 ± 17.58

70.74 ± 14.25

-5.81 (15.08)

0.0852

0.39

42

48.74 ± 24.60

48.45 ± 19.88

-0.28 (16.92)

0.9143

0.02

Pain and Discomfort

21

56.97 ± 27.25

46.80 ± 22.74

-10.16 (19.97)

0.0302

0.51

42

34.87 ± 24.36

35.98 ± 20.84

1.11 (17.80)

0.6873

0.06

Muscle Spasms

23

56.48 ± 18.21

41.69 ± 14.04

-14.79 (22.45)

0.0045

0.66

41

32.20 ± 21.47

29.97 ± 17.11

-2.23 (17.49)

0.4189

0.13

Activities of Daily Living

24

67.30 ± 26.55

66.49 ± 26.15

-0.80 (12.65)

0.7581

0.06

38

34.99 ± 30.53

34.94 ± 26.98

-0.06 (17.05)

0.9840

0.00

Walking

15

72.44 ± 21.10

68.67 ± 21.63

-3.78 (20.47)

0.4864

0.18

38

60.10 ± 27.02)

59.47 ± 28.45

-0.62 (21.07)

0.8562

0.03

Body Movements

22

74.10 ± 22.20

66.36 ± 22.23

-7.74 (17.01)

0.0446

0.46

41

49.31 ± 28.93

45.97 ± 24.53

-3.33 (20.39)

0.3014

0.16

Emotional Health

22

43.50 ± 24.11

32.05 ± 23.84

-11.45 (22.30)

0.0253

0.51

42

30.43 ± 25.26

28.33 ± 24.92

-2.11 (19.49)

0.4876

0.11

Social Functioning

22

49.51 ± 28.48

41.72 ± 24.42

-7.79 (18.97)

0.0677

0.41

41

30.05 ± 25.27

29.81 ± 22.41

-0.25 (23.15)

0.9459

0.01

NRS spasticity

24

6.71 ± 1.55

5.96 ± 1.71

-0.75 (1.26)

0.0078

0.60

41

3.98 ± 2.25

3.71 ± 2.11

-0.27 (1.64)

0.3022

0.16

  1. +T- test.